NASDAQ:VERUVeru Stock Price, Forecast & News

Veru's stock was trading at $3.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VERU stock has decreased by 4.4% and is now trading at $3.06.
View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veru in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Veru.

Veru is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020.
View our earnings forecast for Veru.

Veru will be holding an earnings conference call on Thursday, August 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Veru Inc (NASDAQ:VERU) announced its quarterly earnings data on Wednesday, May, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.03. The business earned $9.94 million during the quarter, compared to the consensus estimate of $11.06 million. Veru had a negative net margin of 25.53% and a negative return on equity of 31.14%.
View Veru's earnings history.

2 equities research analysts have issued 1 year target prices for Veru's stock. Their forecasts range from $6.00 to $9.00. On average, they anticipate Veru's stock price to reach $7.50 in the next twelve months. This suggests a possible upside of 145.1% from the stock's current price.
View analysts' price targets for Veru.

Press coverage about VERU stock has been trending negative this week, according to InfoTrie Sentiment. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Veru earned a news impact score of -2.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.
View the latest news about Veru.

Veru saw a increase in short interest during the month of February. As of February 15th, there was short interest totaling 370,400 shares, an increase of 74.0% from the January 31st total of 212,900 shares. Based on an average trading volume of 401,200 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.8% of the company's stock are short sold.
View Veru's Short Interest.

Some companies that are related to Veru include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV) and Nature's Sunshine Products (NATR).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veru investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Corbus Pharmaceuticals (CRBP), OrganiGram (OGI), Sorrento Therapeutics (SRNE), Vaxart (VXRT), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Kadmon (KDMN) and Inovio Pharmaceuticals (INO).

Veru trades on the NASDAQ under the ticker symbol "VERU."

Veru's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.43%), California Public Employees Retirement System (0.16%), UBS Group AG (0.11%), New York State Common Retirement Fund (0.07%), Raymond James Financial Services Advisors Inc. (0.04%) and SG Americas Securities LLC (0.04%). Company insiders that own Veru stock include Harry Fisch, Jesus Socorro, K Gary Barnette, Michele Greco and Mitchell Shuster Steiner.
View institutional ownership trends for Veru.

VERU stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC.
View insider buying and selling activity for Veru.

VERU stock was bought by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, SG Americas Securities LLC, HighTower Advisors LLC, UBS Group AG, California Public Employees Retirement System, Leap Investments LP, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought Veru stock in the last two years include Harry Fisch, Jesus Socorro, K Gary Barnette, and Michele Greco.
View insider buying and selling activity for Veru.

Shares of VERU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VERU stock can currently be purchased for approximately $3.06.

Veru has a market capitalization of $208.10 million and generates $31.80 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.19) on an earnings per share basis. Veru employs 171 workers across the globe.

The official website for Veru is www.veruhealthcare.com.

Veru's mailing address is 48 NW 25th Street Suite 102, Miami FL, 33127. The company can be reached via phone at 305-509-6897 or via email at [email protected]